[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.238.248.103. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 208
Citations 0
Comment & Response
July 1, 2020

Questions on a Randomized Clinical Trial of Stellate Ganglion Block for Patients With Posttraumatic Stress Disorder—Reply

Author Affiliations
  • 1RTI International, Research Triangle Park, North Carolina
JAMA Psychiatry. Published online July 1, 2020. doi:10.1001/jamapsychiatry.2020.1822

In Reply On behalf of our coauthors, we thank Dr Stein for his interest in our study, “Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial.”1 We are pleased to have the opportunity to address his questions.

Regarding the question about why the study enrolled fewer patients than were indicated in our ClinicalTrials.gov registration2: enrollment failed to meet estimates used for the study design in the trial’s first months. An interim sample size reestimation pooling all participants and conducted when the first 82 participants had 8-week data was conducted by analysts blinded to treatment regimen. The observed SD in the Clinician-Administered PTSD Scale for the DSM-5 (CAPS-5) score at 8 weeks was lower (12.4) than that used in the initial sample size estimate (25). Using this revised SD, we estimated that a smaller sample size of 100 to 120 participants (the range that appeared likely with a fixed additional recruitment period of 9 months) would provide reasonable power (80%-95%) to detect a difference of 10 to 15 points in CAPS-5 total symptom severity scores (TSSSs) between the 2 treatment groups. The study sample size was adjusted accordingly.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×